After pulling its ALS drug Relyvrio from the market, Amylyx Pharmaceuticals is looking to target the GLP-1 space with the purchase of Eiger BioPharmaceuticals avexitide, which has been studied for the treatment of hyperinsulinemic hypoglycemia
Medical Home: RMHP uses medical homes to help achieve savings while meeting quality targets
The mitochondrial permeability transition porecurrent knowledge of its structure, function, and regulation, and optimized methods for evaluating its functional state
In general, all three are less likely to be covered by insurance companies when prescribed for weight loss
Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC